Compare FLEX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLEX | TEVA |
|---|---|---|
| Founded | 1990 | 1901 |
| Country | United States | Israel |
| Employees | N/A | 32842 |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.9B | 40.5B |
| IPO Year | 1997 | N/A |
| Metric | FLEX | TEVA |
|---|---|---|
| Price | $121.35 | $35.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $66.89 | $38.63 |
| AVG Volume (30 Days) | 4.7M | ★ 5.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.43 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $28,679,925,000.00 | N/A |
| Revenue This Year | $8.14 | N/A |
| Revenue Next Year | $6.28 | $2.97 |
| P/E Ratio | $161.86 | ★ $28.19 |
| Revenue Growth | ★ 18.95 | N/A |
| 52 Week Low | $47.83 | $16.27 |
| 52 Week High | $166.86 | $37.35 |
| Indicator | FLEX | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 59.54 |
| Support Level | $58.64 | $30.42 |
| Resistance Level | $131.68 | $35.47 |
| Average True Range (ATR) | 7.86 | 1.12 |
| MACD | 1.15 | 0.39 |
| Stochastic Oscillator | 73.05 | 83.09 |
Flex Ltd is the developed, end-to-end manufacturing partner of choice that helps a diverse customer base design, build, deliver and manage products that improve the world. The Company's full suite of specialized capabilities includes design and engineering, supply chain, manufacturing, and integrated services, plus a portfolio of power and cooling products. Its reportable segments includes Integrated Technology Solutions, Regulated Manufacturing Solutions, and Cloud and Power Infrastructure.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.